224 related articles for article (PubMed ID: 12883323)
41. Selective iNOS inhibition prevents hypotension in septic rats while preserving endothelium-dependent vasodilation.
Strunk V; Hahnenkamp K; Schneuing M; Fischer LG; Rich GF
Anesth Analg; 2001 Mar; 92(3):681-7. PubMed ID: 11226101
[TBL] [Abstract][Full Text] [Related]
42. Effects of aminoguanidine and N(omega)-nitro-L-arginine methyl ester on vascular hyporeactivity induced by endotoxaemia.
Ismailoglu UB; Pekiner C; Yorganci K; Sahin-Erdemli I
Eur J Surg; 2001 Nov; 167(11):803-9. PubMed ID: 11848232
[TBL] [Abstract][Full Text] [Related]
43. Modulation of vascular reactivity in normal, hypertensive and diabetic rat aortae by a non-antioxidant flavonoid.
Ajay M; Achike FI; Mustafa MR
Pharmacol Res; 2007 May; 55(5):385-91. PubMed ID: 17317209
[TBL] [Abstract][Full Text] [Related]
44. Effects of chronic nicotine ingestion on pressor response to Nomega-Nitro-L-arginine methyl ester and ex vivo concentration and relaxation response of aorta to L-arginine.
Hui S; Mei Q; Qiu B
Pharmacol Res; 1997 Dec; 36(6):451-6. PubMed ID: 9446711
[TBL] [Abstract][Full Text] [Related]
45. Baicalein impairs vascular tone in normal rat aortas: role of superoxide anions.
Machha A; Achike FI; Mohd MA; Mustafa MR
Eur J Pharmacol; 2007 Jun; 565(1-3):144-50. PubMed ID: 17442302
[TBL] [Abstract][Full Text] [Related]
46. Impairment of smooth muscle function of rat thoracic aorta in an endothelium-independent manner by long-term administration of N(G)-nitro-L-arginine methyl ester.
López RM; Ortíz CS; Ruíz A; Vélez JM; Castillo C; Castillo EF
Fundam Clin Pharmacol; 2004 Dec; 18(6):669-77. PubMed ID: 15548238
[TBL] [Abstract][Full Text] [Related]
47. Long-term inhibition of RhoA attenuates vascular contractility by enhancing endothelial NO production in an intact rabbit mesenteric artery.
Shiga N; Hirano K; Hirano M; Nishimura J; Nawata H; Kanaide H
Circ Res; 2005 May; 96(9):1014-21. PubMed ID: 15817883
[TBL] [Abstract][Full Text] [Related]
48. Endothelium negatively modulates the vascular relaxation induced by nitric oxide donor, due to uncoupling NO synthase.
Bonaventura D; Lunardi CN; Rodrigues GJ; Neto MA; Vercesi JA; de Lima RG; da Silva RS; Bendhack LM
J Inorg Biochem; 2009 Oct; 103(10):1366-74. PubMed ID: 19699534
[TBL] [Abstract][Full Text] [Related]
49. Estrogen ameliorates Nomega-nitro-L-arginine methyl ester-induced blood pressure increment in male spontaneously hypertensive rats: the role of cGMP.
Yen CH; Wang YR; Huang CF; Lau YT
Chin J Physiol; 2004 Dec; 47(4):183-7. PubMed ID: 15803751
[TBL] [Abstract][Full Text] [Related]
50. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F
Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779
[TBL] [Abstract][Full Text] [Related]
51. The methyl ester of rosuvastatin elicited an endothelium-independent and 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent relaxant effect in rat aorta.
López-Canales JS; López-Sanchez P; Perez-Alvarez VM; Wens-Flores I; Polanco AC; Castillo-Henkel E; Castillo-Henkel C
Braz J Med Biol Res; 2011 May; 44(5):438-44. PubMed ID: 21445535
[TBL] [Abstract][Full Text] [Related]
52. Hydralazine prevents endothelial dysfunction, but not the increase in superoxide production in nitric oxide-deficient hypertension.
Bauersachs J; Bouloumié A; Fraccarollo D; Hu K; Busse R; Ertl G
Eur J Pharmacol; 1998 Nov; 362(1):77-81. PubMed ID: 9865534
[TBL] [Abstract][Full Text] [Related]
53. Arterial function in nitric oxide-deficient hypertension: influence of long-term angiotensin II receptor antagonism.
Kalliovalkama J; Jolma P; Tolvanen JP; Kähönen M; Hutri-Kähönen N; Wu X; Holm P; Pörsti I
Cardiovasc Res; 1999 Jun; 42(3):773-82. PubMed ID: 10533618
[TBL] [Abstract][Full Text] [Related]
54. Nitric oxide mediated endothelium-dependent relaxation induced by glibenclamide in rat isolated aorta.
Chan W; Yao X; Ko W; Huang Y
Cardiovasc Res; 2000 Apr; 46(1):180-7. PubMed ID: 10727666
[TBL] [Abstract][Full Text] [Related]
55. Characterization of endothelium-derived relaxing factors released by bradykinin in human resistance arteries.
Ohlmann P; Martínez MC; Schneider F; Stoclet JC; Andriantsitohaina R
Br J Pharmacol; 1997 Jun; 121(4):657-64. PubMed ID: 9208131
[TBL] [Abstract][Full Text] [Related]
56. Erythropoietin attenuated vascular dysfunction and inflammation by inhibiting NADPH oxidase-derived superoxide production in nitric oxide synthase-inhibited hypertensive rat aorta.
Toba H; Kojima Y; Wang J; Noda K; Tian W; Kobara M; Nakata T
Eur J Pharmacol; 2012 Sep; 691(1-3):190-7. PubMed ID: 22796671
[TBL] [Abstract][Full Text] [Related]
57. Simvastatin improves diabetes-induced coronary endothelial dysfunction.
Tawfik HE; El-Remessy AB; Matragoon S; Ma G; Caldwell RB; Caldwell RW
J Pharmacol Exp Ther; 2006 Oct; 319(1):386-95. PubMed ID: 16849625
[TBL] [Abstract][Full Text] [Related]
58. Lack of nitric oxide mediation of flow-dependent arteriolar dilation in type I diabetes is restored by sepiapterin.
Bagi Z; Koller A
J Vasc Res; 2003; 40(1):47-57. PubMed ID: 12644725
[TBL] [Abstract][Full Text] [Related]
59. Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations.
El-Mas MM; Mohy El-Din MM; El-Gowilly SM; Sharabi FM
Eur J Pharmacol; 2004 Mar; 487(1-3):149-58. PubMed ID: 15033387
[TBL] [Abstract][Full Text] [Related]
60. Endothelium-independent relaxation of aortic rings by the nitric oxide synthase inhibitor diphenyleneiodonium.
Dodd-o JM; Zheng G; Silverman HS; Lakatta EG; Ziegelstein RC
Br J Pharmacol; 1997 Mar; 120(5):857-64. PubMed ID: 9138692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
